Brief: 4D Molecular Therapeutics Q2 Net Income USD -34.953 Million Vs. IBES Estimate USD -37.7 Million
08/08/2024 21:05
Aug 08 (Reuters) - 4D Molecular Therapeutics Q2 revenue USD 5 thousand vs. IBES estimate USD 1.31 million. * Q2 operating income USD -42.456 million vs. IBES estimate USD -39.7 million * Q2 basic EPS USD -0.63 * Q2 operating expenses USD 42.461 million
Recent news on 4D Molecular Therapeutics
See all news4D Molecular Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
4D Molecular Therapeutics Q2 net loss widens
Brief: 4D Molecular Therapeutics Q2 Net Income USD -72.936 Million Vs. IBES Estimate USD -70.3 Million
4D Molecular Therapeutics Inc expected to post a loss of $1.02 a share - Earnings Preview
Brief: 4d Molecular Therapeutics Says 4D-150 Continues To Be Well Tolerated With No New Safety Findings